Breast Cancer Female clinical trials

Explore recruiting breast cancer female clinical trials.

Recruiting breast cancer female studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Breast Cancer Female trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicentre, prospective, open-label study with [68Ga]Ga-ABY-025 PET-imaging to characterize HER2-expression and explore the therapy-predictive value for HER2-antibody drug conjugates in patients with metastatic breast cancer (HER2-Ex PET)

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Pilot study to explore the diagnostic value of gadopiclenol in pathological and radiological insights with multiparametric MRI enhancement in breast cancer.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

TailorDose®-II: Therapeutic dose monitoring of commonly used cytostatic drugs/regimes indicated for breast cancer

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Prevention of cardiac Dysfunction during Adjuvant breast cancer therapy: A Randomized, Placebo-controlled, Multicenter Trial (PRADA-II)

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

GERICO11_Adjuvant systemic treatment for oestrogen-receptor (ER)-positive HER2-negative breast carcinoma in women over 70 according to Genomic Grade (GG): chemotherapy + endocrine treatment versus endocrine treatment. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) multicentre phase III trial

Belgium, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

The POWER trial: A randomised, two-armed open label phase 3 clinical trial on personalised dose optimisation with adjuvant tamoxifen therapy after breast cancer to investigate the impact on discontinuation and efficacy compared to standard of care

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Breast Cancer Female trials by city

Breast Cancer Female in Toronto Breast Cancer Female in Vancouver Breast Cancer Female in Montreal Breast Cancer Female in Calgary Breast Cancer Female in Edmonton Breast Cancer Female in Ottawa Breast Cancer Female in Winnipeg Breast Cancer Female in Quebec City Breast Cancer Female in Hamilton Breast Cancer Female in Kitchener Breast Cancer Female in London Breast Cancer Female in Halifax Breast Cancer Female in New York Breast Cancer Female in Los Angeles Breast Cancer Female in Chicago Breast Cancer Female in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease